Personalized medicine looks at a patient’s genome, but precision medicine takes more of their social and individual determinants into account, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Personalized medicine looks at a patient’s genome, but precision medicine takes more of their social and individual determinants into account, said Leonard M. Fromer, MD, FAAFP, executive medical director of the Group Practice Forum.
Transcript (slightly modified)
What is the difference between personalized medicine and precision medicine?
Historically, when we talked about individualizing treatment for patients we called it personalized medicine. And when that was happening, everybody focused on the genomics of it: how did the patient’s genome impact what they needed in terms of diagnosis and treatment? And what grew out of that was this precision medicine concept.
It has now been embedded in what the president has proposed and the federal government is pursuing in terms of a precision medicine initiative. And what it does is, it takes into account not just the genomics, but adds in for each individual person all of the other drivers around their uniqueness. Pretty much, a lot about the social determinants of patients’ health outcomes. And all of the inputs get put together into a model of what’s different about that patient, what’s unique, and that we have to approach each patient in that unique way to be precise, to deliver precision diagnosis and precision intervention, to help that patient get the best results.
Dr Kathryn Lindley Explains the Importance of Cardio-Obstetrics in Fellowship Programs
December 5th 2023Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, talks about why it’s important to incorporate cardio-obstetrics training into cardiovascular disease fellowship programs.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Christine Pfaff on Ensuring Patient Access to Affordable Treatments
October 17th 2023To ensure patients are getting timely access to their treatments, there needs to be better collaboration between payers and providers, said Christine Pfaff, RPh, senior regional director of operations, American Oncology Network.
Read More